Consensus report: 'Irritable bowel syndrome' - Definition, diagnosis, pathophysiology and therapeutic options - Consensus of the German Society for Digestive and Metabolic Diseases (DGVS);Konsensusbericht: Reizdarmsyndrom - Definition, diagnosesicherung, pathophysiologie und therapiemoglichkeiten - Konsensus der Deutschen Gesellschaft fur Verdauungs- und Stoffwechselkrankheiten

Zeitschrift fur Gastroenterologie

Volumn 37, Issue 8, 1999, Pages 685-700

  Hotz, J ^a   Enck, P ^b   Goebell, H ^b   Heymann Monnikes I ^b   Holtmann, G ^b   Layer, P ^b  

^a ALLGEMEINES KRANKENHAUS CELLE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; DIPHENOXYLATE; FLUOXETINE; FLUSPIRILENE; LOPERAMIDE; MEBEVERINE; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; PINAVERIUM; PROKINETIC AGENT; SCOPOLAMINE BUTYL BROMIDE; SULPIRIDE;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DRUG INDICATION; HUMAN; IRRITABLE COLON; MEDICAL SOCIETY; NOMENCLATURE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; SOCIOECONOMICS; COLON; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; GERMANY; MULTIMODALITY CANCER THERAPY; PATIENT CARE;

COLON; COLONIC DISEASES, FUNCTIONAL; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; GERMANY; HUMANS; PATIENT CARE TEAM;

EID: 0033174935     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Drossman DA, Thompson WG, Talley NJ et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990; 3: 159-72
2. Drossman DA, Whitehead WE, Camilleri M for the American Gastroenterological Association Patient Care Committee. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 1997; 112: 2120-37
3. Drossman DA, Richter JE, Talley NJ et al. The functional gastrointestinal disorders. Boston, New York, Toronto, London. Little, Brown and Company, 1994
4. Manning AP et al. Towards a positive diagnosis of the irritable bowel. BMJ 1978; 2: 653-4
5. Agreus L, Svärdsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time. Gastroenterology 1995; 109: 671-80
6. Drossman DA, Li Z, Andruzzi E, Temple RD et al. U. S. householder survey on functional gastrointestinal disorders. Dig Dis Sci 1993; 38: 1569-80
7. Heaton KW, O'Donnell LJD, Braddon FEM et al. Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 1992; 102: 1962-7
8. Holtmann G, Goebell H, Talley NJ. Dyspepsia in consulters and non-consulters: Prevalence, health-care, seeking behaviour and risk factors. Eur J Gastroenterol Hepatol 1994; 6: 917-24
9. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90
10. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: Prevalence, incidence, natural history and risk factors. J Intern Med 1994; 236: 23-30
11. Schlemper R, van der Werf SDJ, Vandenbroucke JP, Biemond I, Lamers CBHW. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in the Netherlands and Japan. Scand J Gastroenterol Suppl 1993; 200: 33-41
12. Talley NJ, Zinsmeister AR, van Dyke C, Melton LJIII. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-34
13. Zuckerman MJ, Guerra LG, Drossman DA, Foland JA, Gregory GG. Comparison of bowel patterns in hispanic and non-hispanic whites. Dig Dis Sci 1995; 40: 1763-9
14. Talley et al. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990; 31: 77-81
15. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of the life in the elderly: A population-based study. J Gerontol A Biol Sci Med Sci 1995; 50: M184-9
16. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995; 40: 584-9
17. Wilhelmsen I. Quality of life in upper gastrointestinal disorders. Scand J Gastroenterol Suppl 1995; 30: 21-5
18. Nyrén O, Lindberg G, Lindström E, Marke LA, Seensalu R. Economic costs of functional dyspepsia. Pharmaco Economics 1992; 1: 312-24
19. Taub E, Cuevas JL, Cook EW, Crowell M. Whitehead WE. Irritable bowel syndrome defined by factor analysis: Gender and race comparisons. Dig Dis Sci 1995; 40: 2647-55
20. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91: 845-52
21. Holtmann G, Talley NJ, Goebell H. Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci 1996; 41: 1285-91
22. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: Is there a common pathophysiological basis? Am J Gastroenterol 1997; 92: 954-9
23. Lémann M, Dederding JP, Flourie B et al. Abnormal perception of visceral pain in response to gastric distension in gastric idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci 1991; 36: 1249-54
24. Whitehead WE, Holtkoetter B, Enck P et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990; 98: 1187-92
25. Smart HI, Nicholson DA, Atkinson M. Gastroesophageal reflux in the irritable bowel syndrome. Gut 1986; 27: 1227-31
26. Evans PR, Bak YT, Shuter B, Hoschl R, Kellow JE. Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci 1997; 42: 2087-93
27. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987; 92: 1885-93
28. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJIII. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Amer J Epidemiol 1992; 136: 165-77
29. McKendrick MW, Read NW. Irritable bowel syndrome - post salmonella infection. J Infect 1994; 29: 1-3
30. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. BMJ 1997; 119-82
31. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. 1995; 347: 150-3
32. Enck P, Schäfer R. Psychosoziale Faktoren beim M. Crohn. Z Gastroenterol 1996; 34: 708-13
33. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825-30
34. Drossman DA, Leserman J, Nachman G et al. Sexual and physical abuse in women with functional organic disorders. Ann Intern Med 1990; 113: 828-33
35. Delvaux M, Denis P, Allemand H and the French Club of Digestive Motility. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive disease or controls. Results of a multicentre inquiry. Eur J Gastroenterol Hepatol 1996; 9: 345-52
36. Jones VA, McLaughlan P, Shorthous M, Workman E, Hunter JO. Food intolerance: A major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982; 2: 1115-7
37. Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989; 30: 1099-104
38. Sullivan G, Blewett AE, Jenkins PL, Allison MC. Eating attitudes and the irritable bowel syndrome. Gen Hosp Psychiatry 1997; 19: 62-4
39. Zwetschenbaum JF, Burakoff R. Food allergy and the irritable bowel syndrome. Am J Gastroenterol 1988; 83: 901-4
40. Enck P, Wienbeck M. Epidemiology and psychological factors of the irritable bowel syndrome. Europ J Gastroenterol Hepatol 1993; 5: 979-89
41. Greene B, Blanchard EB. Cognitive therapy for irritable bowel syndrome. J Consult Clin Psychol 1994; 62: 576-82
42. Lampe JW, Fredstrom SB, Slavin JL, Potter JD. Sex differences in colonic function: A randomised trial. Gut 1993; 34: 531-6
43. Whitehead WE, Cheskin LJ, Heller BR et al. Evidence for axacerbation of irritable bowel syndrome during menses. Gastroenterology 1990; 98: 1485-9
44. Enck P, Whitehead WE. Gastrointestinal disorders. In: Blechman EA, Brownell KD (eds.). Handbook of Behavioral Medicine for Women. New York. Pergamon, 1988, 178-94
45. Enck P, Kremer A, Kuhlbusch R et al. Prevalence of lactose malabsorption among patients with functional bowel disorders. Z Gastroenterol 1990; 28: 239-41
46. Talley et al. A patients questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4
47. Drossman DA, Whitehead WE, Camilleri M. American gastroenterological association medical position statement: Irritable bowel syndrome. Gastroenterology 1997; 112: 2118-9
48. Francis CY, Whorrwell PJ. The irritable bowel syndrome. Postgrad Med J 1997; 73: 1-7
49. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: Long-term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122: 107-12
50. Kruis W, Thieme Ch, Weinzierl M, Schüssler P et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984; 87: 1-7
51. Thompson WG et al. Irritable bowel syndrome: Guidelines for diagnosis. Gastroenterol Int 1989; 2: 92-5
52. Thompson WG et al. Functional bowel disorders and functional abdominal pain. Gastroenterol Int 1992; 5: 75-91
53. Maxton DG et al. Abdominal distension in female patients with IBS: An investigation of possible mechanisms. Gut 1991; 32: 662-4
54. Lynn RB, Friedman LS. Current Concepts: Irritable bowel syndrome. N Engl J Med 1993; 329: 1940-5
55. Lynn RB, Friedman LS. Irritable bowel syndrome. Managing the patient with abdominal pain and altered bowel habits. Med Clin North Am 1995; 79: 373-90
56. Weber FH, McCallum RW. Clinical approaches to irritable bowel syndrome. Lancet 1992; 340: 1447-52
57. Drossman DA, Thompson WG. The irritable bowel syndrome: A review and a graduated multicomponent treatment approach. Amer Coll Phys 1992; 116: 1009-16
58. Hotz J, Plein K. Empfehlungen zur Therapie des Colon irritabile. Verdauungskrh 1997; 15: 196-9
59. Bennett P, Wilkinson A. A comparison of psychological and medical treatment of the irritable bowel syndrome. Br J Clin Psvchol 1985; 24: 215-6
60. Blanchard MB, Greene B, Scharf MD, Schwarz-McMorris SP. Relaxation training as a treatment of irritable bowel syndrome. Biofeedback and Self-Regulation 1993; 18: 125-32
61. Heaton KW. Role of dietary fibre in irritable bowel syndrome. Irritable bowel syndrome N. W. Read (ed.). London, Grune & Stratton, 1985; pp203-22
62. Lembo T. Fiber and its effect on colonic function in health and disease. Curr Opin Gastroenterol 1998; 14: 1-5
63. Klein KB. Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterol 1988; 95: 232-41
64. Müller-Lissner SA. Effect of wheat bran on weight of stool and gastrointestinal transit time: A meta analysis. BMJ 1988; 615-7
65. Pace F, Coremans G, Dapogny M et al. Therapy of irritable bowel syndrome - an overview. Digestion 1995; 56: 433-42
66. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: Time for reappraisal. Lancet 1994; 344: 39-40
67. Edwards CA, Eastwood MA. Comparison of the effects of isphagula and wheat bran on rat caecal and colonic fermentation. Gut 1992; 33: 1229-33
68. Hamilton JW, Wagner J, Burdickk BB, Bass P. Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci 1988; 33: 993-8
69. Marteau P, Flourié B, Cherbut C et al. Digestibility and bulking effect of isphaghula husks in healthy humans. Gut 1994; 35: 1747-52
70. Ligny G. Therapie des Colon irritabile. Kontrollierte Doppelblindstudie zur Prüfung der Wirksamkeit einer hemizellulosehaltigen Arzneizubereitung. Therapeutikon 1988; 7: 449-53
71. Hotz J, Plein K. Wirkung von Plantago-Samenschalen im Vergleich zu Weizenkleie auf Stuhlfrequenz und Beschwerden beim Colon irritabile-Syndrom mit Obstipation. Med Klin 1994; 89: 645-51
72. Marlett JA, Li BUK, Patrow CJ, Bass P. Comparative laxation of psyllium with and without senna in an ambulatory constipated population. Amer J Gastroenterol 1987; 82: 333-7
73. Ritchie JA, Truelove SC. Comparison of various treatment for irritable bowel syndrome. BMJ 1980; 281: 1317-9
74. Schuster MM. Pharmacology and Therapeutics. G. Friedman et al (ed.). Philadelphia, Lippincott-Raven Publishers, 1997, pp 127-31
75. Sperling RM, McQuaid KR. Rational medical therapy of functional GI disorders. In: Handbook of functional gastrointestinal disorders. K. W. Olden (ed.). New York, Marcel Dekker, Inc., 1996, pp269-28
76. Poynard T, Naveau S, Mory B, Chaput JC. Metaanalysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 499-10
77. Ivey KW. Are anticholinergics of use in the irritable colon syndrome? Gastroenterol 1975; 68: 1300-7
78. Passaretti S, Tittobello A, Capozzi C, Verlinden M. Cisapride accelerates total intestinal transit in patients with irritable bowel syndrome-associated constipation. Prog Med 1987; 43: 121-9
79. Van Outryve M, Milo R, Toussaint J et al. »Prokinetic« treatment of constipation-predominant irritable bowel syndrome: A placebo-controlled study of cisapride. J Clin Gastroenterol 1991; 13: 49
80. Cann PA, Read NW, Holdsworth CD, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome. Dig Dis Sci 1984; 29: 239-47
81. Weiss RF, Fintelmann V. Lehrbuch der Phytotherapie. 8. Auflage. Stuttgart, Hippokrates, 1997
82. Hotz J, Madisch A, Plein K et al. Die Wirksamkeit des Phytotherapeutikums Iberogast® auf die Beschwerden beim Reizdarmsyndrom: Eine placebo-kontrollierte randomisierte Doppelblindstudie. (Unveröffentlichte Daten)
83. Bensoussan A, Talley NJ, Hing M et al. Treatment of irritable bowel syndrome with Chinese herbal medicine. A randomized controlled study. Jama 1998; 280: 1585-9
84. Wedding U, Geiss HK, Theilmann L, Stremmel W. Candida-Besiedlung und Befall des Gastrointestinaltrakts. Dtsch Ärztebl 1995; 92: 3470
85. Camilleri M, Neri M. Motility disorders and stress. Dig Dis Sci 1989; 34: 1777-86
86. Drossman D, Sandler RS, McKee DC, Lovitz AJ. Bowel patterns among subjects not seeking health care. Gastroenterology 1982; 83: 529-34
87. Kutscher S, Holtmann G, Ewald U, Goebell H. German IBDQ Study Group. Intensity of intestinal and extraintestinal symptoms in patients with inflammatory bowel disease and functional dyspepsia. Gastroenterology 1997; 112: A769
88. Blanchard EB, Schwarz SP, Suls JM et al. Two controlled evaluations of multi-component psychological treatment of irritable bowel syndrome. Behav Res Ther 1992; 30: 175-89
89. Corney RH, Stanton R, Newell R, Clare A, Fairclough P. Behavioral psychotherapy in the treatment of irritable bowel syndrome. Journal of Psychosom Res 1991; 35: 461-9
90. Lynch PM, Zamble EA. A controlled behavioral treatment study of irritable bowel syndrome. Behav Res Ther 1989; 509-23
91. Neff DF, Blanchard EB. A multi component treatment for irritable bowel syndrome. Behav Res Ther 1987; 18: 70-83
92. Rumsey N. Group stress management programmes vs pharmacological treatment in the treatment of irritable bowel syndrome. In: Heaton KW, Creed F and Geoting NLM. Toward confident management of irritable bowel syndrome: Current approaches. London, Duphar Medical Relations, 1991, 33-9
93. Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991; 100: 450-7
94. Svedlund J. Sjödin I, Ottosson JO, Dotevall G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet II 1983; 589-92
95. Van Dulmen AM, Fennis JF, Bleijenberg G. Cognitive-behavioral group therapy for irritable bowel syndrome: Effects and long-term follow-up. Psychosom Med 1996; 58: 508-14
96. Jacobson E. Spastic esophagus and mucous colitis -Etiology and treatment by progressive relaxation. Arch Intern Med 1927; 39: 433-45
97. Harvey RF, Hintin RA, Gunary RM, Barry RE. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989; 424-5
98. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in serve irritable bowel syndrome: Further experience. Gut 1987; 28: 423-5
99. Whorwell PJ, Prior A, Fargher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet 1984; 122: 1232-3